Advertisement Boston Imaging Core Lab Collaborates With Chondrometrics - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Boston Imaging Core Lab Collaborates With Chondrometrics

To broaden and advance capabilities to offer imaging biomarker analysis

Chondrometrics and Boston Imaging Core Lab (BICL) have formed a partnership to broaden and advance their capabilities for offering imaging biomarker analysis to osteoarthritis researchers in academia and pharmaceutical industry.

Dr. Guermazi, president, BICL, said: We are excited about this partnership and look forward to extending our already strong research collaboration into a closer strategic co-operation between the two companies.

Dr. Eckstein, CEO of Chondrometrics, said: This will allow us to offer the full spectrum of osteoarthritis imaging biomarkers, both quantitative and semi-quantitative, which recent research has been proven to provide complimentary and synergistic rather than competing or overlapping information in clinical trials.

Chondrometrics is a provider of software-based quantitative medical image analysis, with a focus on articular cartilage and other joint structures in osteoarthritis.

BICL is a provider of semi-quantitative radiological reading services, which are based on advanced radiological scoring systems, including all relevant joint tissues affected by osteoarthritis.